Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

Por Prat, Aleix, Adamo, Barbara, Cheang, Maggie C.U., Anders, Carey K., Carey, Lisa A., Perou, Charles M.
Publicado em 2013

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Por Tischkowitz, Marc, Brunet, Jean-Sébastien, Bégin, Louis R, Huntsman, David G, Cheang, Maggie CU, Akslen, Lars A, Nielsen, Torsten O, Foulkes, William D
Publicado em 2007

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases

Por Rajput, Ashish B., Turbin, Dmitry A., Cheang, Maggie CU, Voduc, David K., Leung, Sam, Gelmon, Karen A., Gilks, C. Blake, Huntsman, David G.
Publicado em 2007

Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

Por Romero, Atocha, Martín, Miguel, Cheang, Maggie C.U., López García-Asenjo, José Antonio, Oliva, Belén, He, Xiaping, de la Hoya, Miguel, García Sáenz, Jose Ángel, Arroyo Fernández, Manuel, Díaz Rubio, Eduardo, Perou, Charles M., Llopis, Trinidad Caldés
Publicado em 2011

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor positive breast cancer

Por Nielsen, Torsten O., Parker, Joel S, Leung, Samuel, Voduc, David, Ebbert, Mark, Vickery, Tammi, Davies, Sherri R., Snider, Jacqueline, Stijleman, Inge J., Reed, Jerry, Cheang, Maggie C.U., Mardis, Elaine R., Perou, Charles M., Bernard, Philip S., Ellis, Matthew J.
Publicado em 2010

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Por Parker, Joel S., Mullins, Michael, Cheang, Maggie C.U., Leung, Samuel, Voduc, David, Vickery, Tammi, Davies, Sherri, Fauron, Christiane, He, Xiaping, Hu, Zhiyuan, Quackenbush, John F., Stijleman, Inge J., Palazzo, Juan, Marron, J.S., Nobel, Andrew B., Mardis, Elaine, Nielsen, Torsten O., Ellis, Matthew J., Perou, Charles M., Bernard, Philip S.
Publicado em 2009

Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial

Por Cheang, Maggie C.U., Voduc, K. David, Tu, Dongsheng, Jiang, Shan, Leung, Samuel, K. Chia, Stephen, Shepherd, Lois E., Levine, Mark N., Pritchard, Kathleen I., Davies, Sherri, Stijleman, Inge J., Davis, Carole, Ebbert, Mark T. W., Parker, Joel S., Ellis, Matthew J., Bernard, Philip S., Perou, Charles M., Nielsen, Torsten O.
Publicado em 2012

Genomic complexity profiling reveals that HORMAD1 overexpression contributes to homologous recombination deficiency in triple-negative breast cancers

Por Watkins, Johnathan, Weekes, Daniel, Shah, Vandna, Gazinska, Patrycja, Joshi, Shalaka, Sidhu, Bhavna, Gillett, Cheryl, Pinder, Sarah, Vanoli, Fabio, Jasin, Maria, Mayrhofer, Markus, Isaksson, Anders, Cheang, Maggie C.U., Mirza, Hasan, Frankum, Jessica, Lord, Christopher J., Ashworth, Alan, Vinayak, Shaveta, Ford, James M., Telli, Melinda L., Grigoriadis, Anita, Tutt, Andrew N.J.
Publicado no Cancer Discov (2015)

Use of mutation profiles to refine the classification of endometrial carcinomas

Por McConechy, Melissa K, Ding, Jiarui, Cheang, Maggie CU, Wiegand, Kimberly, Senz, Janine, Tone, Alicia, Yang, Winnie, Prentice, Leah, Tse, Kane, Zeng, Thomas, McDonald, Helen, Schmidt, Amy P., Mutch, David G., McAlpine, Jessica N, Hirst, Martin, Shah, Sohrab P, Lee, Cheng-Han, Goodfellow, Paul J, Gilks, C. Blake, Huntsman, David G
Publicado em 2012

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

Por Cheang, Maggie C.U., Martin, Miguel, Nielsen, Torsten O., Prat, Aleix, Voduc, David, Rodriguez-Lescure, Alvaro, Ruiz, Amparo, Chia, Stephen, Shepherd, Lois, Ruiz-Borrego, Manuel, Calvo, Lourdes, Alba, Emilio, Carrasco, Eva, Caballero, Rosalia, Tu, Dongsheng, Pritchard, Kathleen I., Levine, Mark N., Bramwell, Vivien H., Parker, Joel, Bernard, Philip S., Ellis, Matthew J., Perou, Charles M., Di Leo, Angelo, Carey, Lisa A.
Publicado no Oncologist (2015)